Objectives. Studies reporting cancer risk after PMR and GCA are few, but it remains an issue of both concern and controversy. We examined the overall and specific cancer risks among Swedish subjects following hospitalization for these diseases.
Introduction
PMR and GCA are closely related disorders that usually occur together [1] . However, they seem to be the same disease with different clinical manifestations, which are based on similar clinical features, such as development in the elderly, similar male to female ratio with more number of females in both, rapid response to glucocorticosteroid treatment and similar outcome [1] . The incidences of PMR and GCA have increased in recent years, with the highest rates noted in northern European countries and in Minnesota (USA). However, the increased incidence could be due to under-reporting or under-diagnosis in the 1970s and 1980s, or because of both, compared with recent years [2] . PMR is two to three times more common than GCA [3] . In the clinical setting, PMR and GCA present with inflammation in the lining of the joints or vessels, resulting from the overproduction of inflammatory cytokines derived from macrophages [4, 5] . The reason for the abnormal immune system response is not known. Family studies have shown that the risk increases when family members are affected with these diseases, suggesting contribution of genetic risk factors [1] .
Patients with dysregulated immune function, such as asthma, RA and psoriasis, have been shown to be associated with an increased cancer occurrence [6] [7] [8] . However, no definite association has been established between PMR and GCA with cancer in the relatively small published studies [9] [10] [11] [12] . We carried out a longitudinal cohort study to quantify the subsequent cancer risk in hospitalized PMR and GCA patients, using Swedish nationwide registers. The present study is by far the largest one on the theme, covering 35 918 patients and allowing a separate analysis of patients with multiple hospitalizations.
Patients and methods
We used the Swedish Hospital Discharge Register, founded in 1964-65 by the National Board of Health and Welfare with complete national coverage since 1987, to create a cohort of PMR and GCA patients. A total of 35 918 patients were identified in the registry. The study cohort was linked to the national Swedish Cancer Registry, founded in 1958 with close to 100% coverage, to ascertain all incident cancers from the start of follow-up until 31 December 2006. Additional linkages were carried out to national census data to obtain individual occupational status, national Registry of Causes of Death to identify date of death and the Emigration Registry to identify date of emigration.
Person-years were calculated from the last hospitalization for PMR and GCA until diagnosis of cancer, death, emigration or closing date (31 December 2006), whichever came first. The follow-up time was divided into four periods: <1, 1-4, 5-9 and 510 years. Standardized incidence ratios (SIRs) were calculated as the ratio of observed to expected number of cases. The expected numbers were calculated using the incidence rates for all individuals without PMR and GCA as reference, and the rates were standardized by 5-year age group, gender, tumour type, period (5-year group), socio-economic status (six groups) and residential area (three groups) [13] . The 95% CIs of the SIR was calculated assuming a Poisson distribution, and they were rounded to the nearest two decimals [13] . All analyses were performed using the SAS statistical package (version 9.1; SAS Institute, Cary, NC, USA). The ethics committee at Lund University, Sweden, approved this study.
Results
A total of 35 918 patients were hospitalized in Sweden for PMR and GCA during the years 1969-2006; among them, 29 831 patients (83%) were hospitalized only once and 6087 patients (17%) had multiple hospital visits. The follow-up times ranged from 0 to 35 years, with a median follow-up of 8 years. Hospitalization was more common in women than in men, but hospitalization rate increased towards late age irrespective of sex. The rate was increased remarkably after the age of 50 years, but decreased somewhat after the age of 80 years (data not shown).
A total of 3941 patients developed subsequent cancer after being hospitalized for PMR and GCA, giving an overall SIR of 1.19 and an SIR of 1.06 for cancer diagnosed later than 1 year after the last hospitalization (all 1+), as shown in Table 1 . Only those cancer sites with at least 20 cases during the whole follow-up period were listed. The risk for some cancers, such as kidney cancer and leukaemia, was very high during the first year, probably because of a concomitant diagnosis. Thus, we show the data for both the whole follow-up period and 1+. The overall risk of cancers in the stomach, lung, prostate, kidney, skin (melanoma and squamous cell), nervous system, endocrine glands and in lympho-haematopoietic tissues (non-Hodgkin's lymphoma, myeloma and leukaemia) was significantly increased. However, excluding cancer cases during the first year after hospitalization, significant excess was noted only for prostate and skin (melanoma and squamous cell) cancers and for leukaemia. For specific subtypes of leukaemia, the risk for acute myeloid leukaemia was significantly increased (SIR 2.15). Risk for endometrial cancer was significantly decreased. We have calculated the subsequent cancer risk following hospitalization of PMR and GCA separately, and the risks were similar for the two diseases (data not shown).
Multiple hospitalizations may reflect the disease severity, and we examined cancer risk among PMR and GCA patients by the number of hospitalizations (Table 2) . Patients diagnosed during the first year of follow-up were excluded from the analysis; the follow-up was started from the last hospitalization. For specific cancer sites, the SIR was higher for cancers in the kidney and skin (melanoma and squamous cell), and for leukaemia when PMR and GCA patients had multiple hospitalizations. The risks were decreased to 0.57 for rectal and endometrial cancers in those with multiple hospitalizations.
Discussion
In this population-based study, 35 918 PMR and GCA patients were identified from the Swedish Hospital Discharge Register and they were followed up until 2006. Overall, a 19% excess incidence of cancers was noted, and the risk was marginally above unity (1.06) on excluding cases diagnosed during the first year of follow-up. This excess was largely attributed to cancers in the skin (melanoma and squamous cell carcinoma) and to leukaemia.
The advantages of the present study include the larger number of patients from a nationwide population and its prospective design and completeness of follow-up of patients. All the data were from nation-wide databases guaranteeing reliable information. However, in this histological cohort study, we had no information on individual risk factors among these patients because these registries were not built for the purpose of study, leading to potential bias. However, the lack of information on individual risk factors could be partly compensated by the adjustment of socio-economic status, which is strongly associated with many risk factors for cancers, such as smoking and diet [1, 14] . In this study, only hospitalized patients, probably www.rheumatology.oxfordjournals.org those representing a severe diagnoses, were included, leading to selection bias. Thus, the data from this study cannot be applicable to all patients with PMR and GCA. Information about other variables, such as medication and treatment, which play an important role in confounding, is lacking in our study, which may make our conclusion difficult to deduce. Because of multiple comparisons, some findings may be due to chance. A formal approach to deal with the problem is to adjust the CIs to the number of comparisons; however, because there is no agreement on how the adjustment should be made, we emphasize the value of high SIRs and 99% CIs [15] . Other pointers are biological plausibility and agreement with previous hypotheses and results. Hospitalization rate for PMR and GCA increased with age, which was in line with the epidemiological data that the incidence rate of PMR and GCA increases progressively after 50 years of age [1] . However, hospitalization rate was somewhat lower than the reported incidence rate in Nordic countries [12, 16] , suggesting that some of these patients may be treated in the outpatient setting. Women were hospitalized more than men, but the difference was less than the reported incidence difference (two or three times more common in women than men) [1] .
To our knowledge, this is the first study to show an increase in overall cancer incidence among PMR and GCA patients. Most of the previous studies were based on a small number of cancers [9] [10] [11] [12] , and many used case-control study design, with possible recall and selection biases. However, the highest risk in this study was noted during the first year after last hospitalization for PMR and GCA, which could be due to lead time bias because of concomitant diagnosis. However, the accuracy of diagnosis of cancers is not compromised by lead time bias, although it can shift the diagnosis earlier [17, 18] . Since the diagnostic criteria, especially for PMR, were neither sensitive nor specific, and we cannot control the diagnosis of these patients, misdiagnosis of underlying cancers as PMR and GCA could contribute somewhat to the excess rate of cancer during the first year. Moreover, PMR and GCA themselves could be paraneoplastic disorders, because the risk of cancer was highest in the first year and weakened with the duration of follow-up, but we had no case-specific details of these patients, precluding our extrapolation.
For specific cancers, 11 cancer sites showed an increased risk for the whole follow-up period. However, some of these cancers were probably in excess because of the increased medical surveillance of the patients. The high risk of endocrine gland tumours during the first year of follow-up could be related to the increased surveillance, as most of these tumours are relatively indolent adenomas. Indeed, only four cancer sites remained significantly in excess when the first year was excluded. The increased occurrence of squamous cell skin cancer and melanoma has not been reported earlier. The two cancers are thought to be the hallmarks of dysregulated immunity, which is in line with the evidence that PMR and GCA are immune-mediated disorders. However, the increased risk of non-Hodgkin's lymphoma, another hallmark for dysregulated immunity, was confined only to the year following the last hospitalization. The highest risk was noted for leukaemia, particularly for acute myeloid leukaemia. The risk remained very high (2.15) even when we excluded acute myeloid leukaemia diagnosed during the first year of follow-up, suggesting there may be a true biological association. The increase in acute myeloid leukaemia has also been observed in a recent study in the USA [19] . A case report study showed that a few patients with PMR had raised prostate-specific antigen level and they were subsequently diagnosed with prostate cancer, which was in line with our observation for the marginal excess of prostate cancer [20] ; however, the biological mechanisms for the association were not known and should be examined further. Interestingly, risk of endometrial cancer was significantly decreased, and a less frequent occurrence of endometrial cancer was also noted for patients with RA and asthma [6, 8] , suggesting that dysregulated immune function could affect oestrogen production [21] . Additionally, rectal cancer was decreased in patients with multiple hospitalizations. We further identified the patient population by the number of hospital visits, using this as a surrogate for disease severity and chronicity. Overall cancer risk was not associated with the number of hospitalizations. However, for specific cancers, the excesses in skin cancer and in leukaemia were most pronounced for patients with multiple hospitalizations. The highest risk was noted for leukaemia among patients with multiple hospitalizations. Multiple hospitalizations relate to the severity of the disease but, additionally, the increased risk of skin cancer and leukaemia should be an extra concern, which may call for medical surveillance.
In summary, the incidence of cancer marginally increased among patients hospitalized for PMR and GCA, with the highest risk noted for the first year after hospitalization, which could be due to lead time bias or misdiagnosis. However, for specific cancers, such as skin cancer and leukaemia, the increases were still significant for patients diagnosed later than 1 year after hospitalization, especially for those with multiple hospitalizations, suggesting that these could be true associations, but the mechanisms remain to be examined and established further.
Rheumatology key messages
. PMR and GCA patients have a 19% overall excess incidence of cancer. . Skin cancer and acute myeloid leukaemia are frequent among PMR and GCA patients.
